5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF; Gao, YD; He, GZ; Wang, YM; Zhu, FF | 1 |
| Di, W; Gu, L; Li, S; Qiu, L; Shen, H; Wu, B; Zhou, L; Zhu, J | 1 |
2 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Disease Models, Animal
| Article | Year |
|---|---|
Different effects of acetyl-CoA carboxylase inhibitor TOFA on airway inflammation and airway resistance in a mice model of asthma.
Topics: Acetyl-CoA Carboxylase; Airway Resistance; Animals; Asthma; Chickens; Disease Models, Animal; Female; Furans; Lung; Mice; Mice, Inbred C57BL; Ovalbumin; Respiratory Hypersensitivity; Treatment Outcome | 2020 |
TOFA suppresses ovarian cancer cell growth in vitro and in vivo.
Topics: Acetyl-CoA Carboxylase; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Furans; Humans; Mice; Ovarian Neoplasms; Xenograft Model Antitumor Assays | 2013 |